[Federal Register Volume 66, Number 203 (Friday, October 19, 2001)]
[Notices]
[Page 53229]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-26388]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting.

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should inform the contact person listed below in 
advance of the meeting. The meeting will be held as a telephone 
conference call with the members. A speaker phone installed in the 
conference room will enable members of the public in attendance to 
listen to the discussion and address the RAC.

    Name of Committee: Recombinant DNA Advisory Committee (RAC).
    Date: November 1, 2001.
    Time: 12-1 p.m.
    Agenda: To discuss and vote on a recommendation to the Director, 
NIH, regarding final action to amend Section IV-C-2 of the NIH 
Guidelines for Research Involving Recombinant DNA Molecules to 
change the prescribed number and expertise of RAC members and 
establish the charter of the RAC as the controlling document for the 
membership and procedures of that committee. The proposed action was 
published in the Federal Register on August 24, 2001 (66 FR 44638).
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 45, Conference Room C1/C2, Bethesda, Maryland 20892.
    Contact: Ms. Laurie Harris, RAC Program Assistant, Office of 
Biotechnology Activities, Rockledge 1, Room 750, Bethesda MD, 20892, 
(301) 496-9839.
    Information is also available on the Institute's/Center's home 
page: www4.od.nih.gov/oba/, where an agenda and any additional 
information for the meeting will be posted when available. OMB's 
``Mandatory Information Requirements for Federal Assistance Program 
Announcements'' (45 FR 39592, June 11, 1980) requires a statement 
concerning the official government programs contained in the Catalog 
of Federal Domestic Assistance. Normally NIH lists in its 
announcements the number and title of affected individual programs 
for the guidance of the public. Because the guidance in this notice 
covers virtually every NIH and Federal research program in which DNA 
recombinant molecules techniques could be used, it has been 
determined not to be cost effective or in the public interest to 
attempt to list these programs. Such a list would likely require 
several additional pages. In addition, NIH could not be certain that 
every Federal program would be included as many Federal agencies, as 
well as private organizations, both national and international, have 
elected to follow the NIH Guidelines, In lieu of the individual 
program listing, NIH invites readers to direct questions to the 
information address above about whether individual programs listed 
in the Catalog of Federal Domestic Assistance are affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Instramural Research Training Award; 93.187, Undergraduate 
Scholarship Program for Individuals from Disadvantaged Backgrounds; 
93.22, Clinical Research Loan Repayment Program for Individuals from 
Disadvantaged Backgrounds; 93.232, Loan Repayment Program for 
Research Generally; 93.39, Academic Research Enhancement Award; 
93.936, NIH Acquired Immunodeficiency Syndrome Research Loan 
Repayment Program, National Institutes of Health, HHS)


    Dated: October 12, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-26388 Filed 10-18-01; 8:45 am]
BILLING CODE 4140-01-M